Increasing the levels of SEMA3B in the hippocampus or the lateral ventricles, improved CMS-induced depression-like behaviors and increased resilience to acute stress by increasing dendritic spine density in hippocampal neurons (Du et al., 2022). The gene discussed is SEMA3B; the disease is depressive symptom measurement.